The University of Chicago Header Logo

Connection

Ravi Salgia to MAP Kinase Kinase Kinase 1

Back to Details
This is a "connection" page, showing publications Ravi Salgia has written about MAP Kinase Kinase Kinase 1.
Ravi Salgia
Connection Strength
0.035
MAP Kinase Kinase Kinase 1
  1. Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer. Ann Oncol. 2016 Apr; 27(4):693-9.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.